These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22171470)

  • 61. Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play.
    Lambour J; Naranjo-Gomez M; Piechaczyk M; Pelegrin M
    Emerg Microbes Infect; 2016 Aug; 5(8):e92. PubMed ID: 27530750
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gene therapy and gene transfer approaches to prevent or treat chronic virus infections.
    Berkout B; Ertl HC; Weinberg MS
    Adv Exp Med Biol; 2015; 848():v-vii. PubMed ID: 26034787
    [No Abstract]   [Full Text] [Related]  

  • 63. Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
    Pelegrin M; Naranjo-Gomez M; Piechaczyk M
    Trends Microbiol; 2015 Oct; 23(10):653-665. PubMed ID: 26433697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Passive immunization as prophylaxis: when and where will this work?
    Dunman PM; Nesin M
    Curr Opin Pharmacol; 2003 Oct; 3(5):486-96. PubMed ID: 14559093
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of schistosomes on host anti-viral immune response and the acquisition, virulence, and prevention of viral infections: A systematic review.
    Bullington BW; Klemperer K; Mages K; Chalem A; Mazigo HD; Changalucha J; Kapiga S; Wright PF; Yazdanbakhsh MM; Downs JA
    PLoS Pathog; 2021 May; 17(5):e1009555. PubMed ID: 34015063
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic vaccination against chronic viral infections.
    Vandepapelière P
    Lancet Infect Dis; 2002 Jun; 2(6):353-67. PubMed ID: 12144898
    [TBL] [Abstract][Full Text] [Related]  

  • 67. T-bodies as antiviral agents.
    Bitton N; Debre P; Eshhar Z; Gorochov G
    Curr Top Microbiol Immunol; 2001; 260():271-300. PubMed ID: 11443878
    [No Abstract]   [Full Text] [Related]  

  • 68. Preventing infectious disease with passive immunization.
    Zeitlin L; Cone RA; Moench TR; Whaley KJ
    Microbes Infect; 2000 May; 2(6):701-8. PubMed ID: 10884621
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Uses of flow cytometry in virology.
    McSharry JJ
    Clin Microbiol Rev; 1994 Oct; 7(4):576-604. PubMed ID: 7530594
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Special issue on therapeutic antibodies and biopharmaceuticals.
    Chung J
    Exp Mol Med; 2017 Mar; 49(3):e304. PubMed ID: 28336954
    [No Abstract]   [Full Text] [Related]  

  • 71. Roadblocks to translational challenges on viral pathogenesis.
    Deeks S; Drosten C; Picker L; Subbarao K; Suzich J
    Nat Med; 2013 Jan; 19(1):30-4. PubMed ID: 23296014
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Anti-infective monoclonals step in where antimicrobials fail.
    Fox JL
    Nat Biotechnol; 2013 Nov; 31(11):952-4. PubMed ID: 24213755
    [No Abstract]   [Full Text] [Related]  

  • 73. [Viral infections and oxidative stress].
    Brkić S; Marić D; Tomić S; Dimitrijević R
    Vojnosanit Pregl; 2010 Dec; 67(12):1015-20. PubMed ID: 21425559
    [No Abstract]   [Full Text] [Related]  

  • 74. Antivirals become a broader enterprise.
    Fox JL
    Nat Biotechnol; 2007 Dec; 25(12):1395-402. PubMed ID: 18066034
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Stacking up the armory against viruses.
    Klebl BM
    Drug Discov Today; 2004 Feb; 9(4):162-4. PubMed ID: 14960395
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nucleated red blood cells: Immune cell mediators of the antiviral response.
    Nombela I; Ortega-Villaizan MDM
    PLoS Pathog; 2018 Apr; 14(4):e1006910. PubMed ID: 29698529
    [No Abstract]   [Full Text] [Related]  

  • 77. Sustained and transient oscillations and chaos induced by delayed antiviral immune response in an immunosuppressive infection model.
    Shu H; Wang L; Watmough J
    J Math Biol; 2014 Jan; 68(1-2):477-503. PubMed ID: 23306425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Exploring the native human antibody repertoire to create antiviral therapeutics.
    Dessain SK; Adekar SP; Berry JD
    Curr Top Microbiol Immunol; 2008; 317():155-83. PubMed ID: 17990793
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeting host cells harbouring viruses with radiolabeled antibodies.
    Casadevall A; Goldstein H; Dadachova E
    Expert Opin Biol Ther; 2007 May; 7(5):595-7. PubMed ID: 17477798
    [TBL] [Abstract][Full Text] [Related]  

  • 80. History and Practice: Antibodies in Infectious Diseases.
    Hey A
    Microbiol Spectr; 2015 Apr; 3(2):AID-0026-2014. PubMed ID: 26104697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.